Breaking News Instant updates and real-time market news.

TENB

Tenable Holdings

$32.07

0.8 (2.56%)

, BRY

Berry Petroleum

$12.94

0.1 (0.78%)

10:29
08/20/18
08/20
10:29
08/20/18
10:29

On The Fly: Top five analyst initiations

Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Tenable Holdings (TENB) initiated with an Outperform at William Blair, a Buy at Stifel, BTIG, and Deutsche Bank, an Equal Weight at Morgan Stanley, as well as a Neutral at JPMorgan. 2. Berry Petroleum (BRY) initiated with an Outperform at Wells Fargo and BMO Capital, an Overweight at Piper Jaffray, as well as a Buy at Goldman Sachs and UBS. 3. Aquestive Therapeutics (AQST) initiated with an Outperform at JMP Securities, BMO Capital, and RBC Capital. 4. Auryn Resources (AUG) initiated with a Buy at H.C. Wainwright. 5. Bloom Energy (BE) initiated with an Overweight at JPMorgan, KeyBanc, and Morgan Stanley, a Market Perform at Cowen, a Perform at Oppenheimer, a Neutral at Credit Suisse and Baird, as well as an Underperform at BofA/Merrill. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

TENB

Tenable Holdings

$32.07

0.8 (2.56%)

BRY

Berry Petroleum

$12.94

0.1 (0.78%)

AQST

Aquestive Therapeutics

$16.00

0.05 (0.31%)

AUG

Auryn Resources

$1.02

(0.00%)

BE

Bloom Energy

$22.32

0.1 (0.45%)

  • 23

    Aug

  • 13

    Sep

TENB Tenable Holdings
$32.07

0.8 (2.56%)

08/20/18
MSCO
08/20/18
INITIATION
Target $31
MSCO
Equal Weight
Tenable Holdings initiated with an Equal Weight at Morgan Stanley
Morgan Stanley analyst Melissa Franchi initiated Tenable Holdings with an Equal Weight rating and $31 price target, stating her view that its "attractive" market, natural growth levers and "compelling" technology are being appropriately valued by its current share price. Her assumption is for a moderation in current billings growth as the company reaches greater scale, but if current growth continues through 2019 while profitability ramps, Tenable could move toward her "bull case" valuation of $52, Franchi added.
08/20/18
STFL
08/20/18
INITIATION
Target $43
STFL
Buy
Tenable Holdings initiated with a Buy at Stifel
Stifel analyst Gur Talpaz initiated Tenable Holdings with a Buy rating and $43 price target, stating that while it is currently a leader in the "increasingly strategic" vulnerability management market it is also evolving into a sophisticated analytics platform. He believes the inclination of investors will be to focus on the vulnerability management market, but recommends they "look past the cover page" and understand how Tenable's ultimate focus is to drive improved security outcomes, Talpaz said.
08/20/18
BTIG
08/20/18
INITIATION
Target $41
BTIG
Buy
Tenable Holdings initiated with a Buy at BTIG
BTIG analyst Joel Fishbein initiated Tenable Holdings with a Buy rating and a price target of $41, citing the company's position of providing security across a range of traditional and more modern IT assets just as the number of connected devices is "surging". The analyst is positive on the company's pricing model strategy of correlating its revenue with the number of covered device growth. Fishbein also believes the stock is inexpensive at 12-times enterprise value to expected FY18 sales, given his estimated annualized revenue growth of over 30% for the next 3 years.
08/20/18
WBLR
08/20/18
INITIATION
WBLR
Outperform
Tenable Holdings initiated with an Outperform at William Blair
William Blair analyst Jonathan Ho initiated Tenable Holdings with an Outperform rating. In a research note to investors, Ho says he views the company as a core cybersecurity name, with both significant growth in traditional assets, IoT, and container security, as well as a strong management team.
BRY Berry Petroleum
$12.94

0.1 (0.78%)

08/20/18
UBSW
08/20/18
INITIATION
Target $17
UBSW
Buy
Berry Petroleum initiated with a Buy at UBS
UBS analyst Lloyd Byrne initiated Berry Petroleum with a Buy rating as he sees the risk/reward skewed positively at 2.5 to 1. He said that places the company in the top half of his coverage and notes it is unique because it is a conventional smaller cap U.S. E&P company with leverage to Brent oil. Byrne has a $17 price target on Berry Petroleum shares.
08/20/18
GSCO
08/20/18
INITIATION
Target $20
GSCO
Buy
Berry Petroleum initiated with a Buy at Goldman Sachs
Goldman analyst John Nelson initiated Berry Petroleum with a Buy and $20 price target saying its non-shale focus and lower maintenance capex levels offer competitive growth and free-cash-flow.
08/20/18
BMOC
08/20/18
INITIATION
Target $18
BMOC
Outperform
Berry Petroleum initiated with an Outperform at BMO Capital
BMO Capital analyst Philip Jungwirth initiated Berry Petroleum with an Outperform rating and a price target of $18. The analyst notes that the company's operating leverage is producing high cash margins, free cash flows, and growth, while its balance sheet strength is "top-tier" among the similar small-to-medium E&P firms. Jungwirth adds that the company's 100% oil production and high net revenue interests in California should allow it to grow output at a double-digit rate in 2019-2020. The analyst further notes that Berry Petroleum trades at a "deep discount" of 3.9-times the FY19 enterprise value to expected EBITDAX relative to the 4.3-times peer group median.
08/20/18
WELS
08/20/18
INITIATION
Target $17
WELS
Outperform
Berry Petroleum initiated with an Outperform at Wells Fargo
Wells Fargo analyst Gordon Douthat started Berry Petroleum with an Outperform rating and $17 price target. With a differentiated asset base, balanced growth profile, and embedded return of capital at a discounted valuation, Berry presents an underappreciated way to gain oil exposure in the small-cap space, the analyst contends.
AQST Aquestive Therapeutics
$16.00

0.05 (0.31%)

08/20/18
JMPS
08/20/18
INITIATION
Target $29
JMPS
Outperform
Aquestive Therapeutics initiated with an Outperform at JMP Securities
JMP Securities analyst Jason Butler initiated Aquestive Therapeutics with an Outperform rating and $29 price target, stating that the benefits of its core oral-film-based delivery technology has been validated through multiple successful partnerships and the company is now leveraging it on an internal pipeline of drug candidates. He believes FDA approvals for wholly owned candidates including Libervant and Sympazan are likely over the next 12-18 months, Butler tells investors.
08/20/18
BMOC
08/20/18
INITIATION
Target $26
BMOC
Outperform
Aquestive Therapeutics initiated with an Outperform at BMO Capital
BMO Capital analyst Gary Nachman initiated Aquestive Therapeutics with an Outperform rating and $26 price target, stating that its PharmFilm drug delivery technology is "best-in-class" and he is "particularly optimistic" about the prospects for Libervant in refractory seizures. The significant near-term catalysts he sees include the Sympazan PDUFA date of August 31 and the filing of Libervant in late Q4, Nachman tells investors.
08/20/18
RBCM
08/20/18
INITIATION
Target $23
RBCM
Outperform
Aquestive Therapeutics initiated with an Outperform at RBC Capital
RBC Capital analyst Randall Stanicky initiated Aquestive Therapeutics with an Outperform rating and a price target of $23. The analyst says the company offers a "validated film delivery technology with applications across a range of therapeutic areas", while developing a near-to-market portfolio of proprietary CNS products headlined by Libervant. Stanicky further states that Aquestive Therapeutics has "stable" cash flows from Suboxone behind it and a "broad pipeline" ahead of it, as it undergoes a "strategic transformation" to generate a "meaningful step up in value" from its proprietary CNS pipeline development to market.
AUG Auryn Resources
$1.02

(0.00%)

10/31/17
ROTH
10/31/17
INITIATION
Target $3
ROTH
Buy
Auryn Resources initiated with a Buy at Roth Capital
Roth Capital analyst Joe Reagor started Auryn Resources with a Buy rating and $3 price target, saying he thinks the company has the team to advance its exploration projects quickly and ultimately he believes the company will look to sell these assets.
08/20/18
HCWC
08/20/18
INITIATION
Target $1.7
HCWC
Buy
Auryn Resources initiated with a Buy at H.C. Wainwright
H.C. Wainwright analyst Heiko Ihle started Auryn Resources with a Buy rating and $1.70 price target, stating that he believes the company's portfolio of seven gold exploration properties has the potential to yield more than one multi-million ounce discovery. Ihle attributes much of the stock's 63% decline from its 52-week high to weakness in the precious metals sector rather than any company specific issues, he tells investors.
BE Bloom Energy
$22.32

0.1 (0.45%)

08/20/18
COWN
08/20/18
INITIATION
Target $24
COWN
Market Perform
Bloom Energy initiated with a Market Perform at Cowen
Cowen analyst Jeffrey Osborne initiated Bloom Energy with a Market Perform rating as he believes shares are fairly valued and trade at a premium to fuel cell peers. He said he is looking forward to the upcoming product cycle, which should drive down LCOE and expand its total addressable market, which would make him more constructive on the stock. Osborne has a $24 price target on Bloom Energy shares.
08/20/18
FBCO
08/20/18
INITIATION
Target $24
FBCO
Neutral
Bloom Energy initiated with a Neutral at Credit Suisse
Credit Suisse analyst Michael Weinstein started Bloom Energy with a Neutral rating and $24 price target. After a nearly 80% jump off the $15 IPO, the analyst believes that current pricing captures a fair balance between the risk of executing continued cost reductions and the possible upside from accelerating sales growth once the investment tax credit sunsets in 2023.
08/20/18
OPCO
08/20/18
INITIATION
OPCO
Perform
Bloom Energy initiated with a Perform at Oppenheimer
Oppenheimer analyst Colin Rusch started coverage of Bloom Energy with a Perform rating. While the analyst sees the potential for the company to be a core solution provider in disrupting the power market and leading to the possibility for multi-decade growth, he sees limited valuation support at current price levels and also sees significant execution in front of Bloom.
08/20/18
BARD
08/20/18
INITIATION
Target $24
BARD
Neutral
Bloom Energy initiated with a Neutral at Baird
Baird analyst Ben Kallo initiated Bloom Energy with an Neutral rating. While he views the growth profile favorably, he thinks further cost reductions are important to growing the company's customer base and achieving profitability. Kallo has a $24 price target on Bloom Energy shares.

TODAY'S FREE FLY STORIES

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
05/24/19
05/24
13:17
05/24/19
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
05/24/19
05/24
13:16
05/24/19
13:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTSH

Cognizant

$61.83

0.75 (1.23%)

13:12
05/24/19
05/24
13:12
05/24/19
13:12
Hot Stocks
Cognizant CEO buys 19K shares of company stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Jun

  • 23

    Jun

NFLX

Netflix

$355.84

3.61 (1.02%)

, GOOG

Alphabet

$1,144.00

3.45 (0.30%)

13:08
05/24/19
05/24
13:08
05/24/19
13:08
Hot Stocks
Netflix to release 'Little Black Mirror' episodes on YouTube starting May 26 »

Netflix Latin America…

NFLX

Netflix

$355.84

3.61 (1.02%)

GOOG

Alphabet

$1,144.00

3.45 (0.30%)

GOOGL

Alphabet Class A

$1,148.10

3.22 (0.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jun

  • 03

    Jun

  • 06

    Jun

  • 19

    Jun

  • 19

    Jun

  • 25

    Jun

  • 27

    Oct

13:07
05/24/19
05/24
13:07
05/24/19
13:07
General news
Baker-Hughes Rig Count N. Amer. data reported »

Week of 5/24 Baker-Hughes…

UAL

United Continental

$81.10

0.19 (0.23%)

, BA

Boeing

$356.58

6.01 (1.71%)

13:07
05/24/19
05/24
13:07
05/24/19
13:07
Periodicals
United extending Boeing 737 Max cancellations through August 3, CNBC reports »

United Airlines (UAL)…

UAL

United Continental

$81.10

0.19 (0.23%)

BA

Boeing

$356.58

6.01 (1.71%)

AAL

American Airlines

$29.41

-0.08 (-0.27%)

LUV

Southwest

$51.33

0.36 (0.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 05

    Jun

  • 12

    Jun

  • 12

    Jun

  • 25

    Jul

  • 13

    Nov

BBY

Best Buy

$64.89

-0.9 (-1.37%)

, SSNLF

Samsung

$0.00

(0.00%)

13:04
05/24/19
05/24
13:04
05/24/19
13:04
Periodicals
Best Buy cancels preorders for Samsung's foldable phone, CNN reports »

Best Buy (BBY) is…

BBY

Best Buy

$64.89

-0.9 (-1.37%)

SSNLF

Samsung

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 30

    May

  • 11

    Jun

BHGE

Baker Hughes

$22.28

-0.78 (-3.38%)

13:03
05/24/19
05/24
13:03
05/24/19
13:03
Hot Stocks
Baker Hughes reports U.S. rig count down 4 to 983 rigs »

Baker Hughes reports that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

V

Visa

$162.59

1.07 (0.66%)

13:02
05/24/19
05/24
13:02
05/24/19
13:02
Hot Stocks
Visa CFO Vasant Prabhu appointed company vice chairman »

Visa announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 05

    Jun

EHC

Encompass Health

$59.22

-0.315 (-0.53%)

13:01
05/24/19
05/24
13:01
05/24/19
13:01
Hot Stocks
Encompass Health names Kim Sullivan chief human resources officer »

Encompass Health…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

IONS

Ionis Pharmaceuticals

$67.35

0.215 (0.32%)

, BIIB

Biogen

$229.80

0.75 (0.33%)

13:01
05/24/19
05/24
13:01
05/24/19
13:01
Hot Stocks
Ionis, Biogen slip after FDA approves Novartis' Zolgensma for SMA treatment »

Shares of Ionis…

IONS

Ionis Pharmaceuticals

$67.35

0.215 (0.32%)

BIIB

Biogen

$229.80

0.75 (0.33%)

NVS

Novartis

$87.21

2.75 (3.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 31

    May

  • 05

    Jun

  • 06

    Jun

  • 17

    Jun

  • 18

    Jun

XRT

S&P Retail Index SPDR

$41.58

-0.09 (-0.22%)

13:00
05/24/19
05/24
13:00
05/24/19
13:00
Options
Size four-way put spread in SPDR Retail Trust as shares extend losses »

Size four-way put spread…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RGNX

Regenxbio

$43.60

1.11 (2.61%)

, NVS

Novartis

$87.13

2.67 (3.16%)

12:53
05/24/19
05/24
12:53
05/24/19
12:53
Hot Stocks
Regenxbio up 6% after Novartis receives FDA approval for Zolgensma »

Regenxbio (RGNX) will…

RGNX

Regenxbio

$43.60

1.11 (2.61%)

NVS

Novartis

$87.13

2.67 (3.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

  • 31

    May

NVS

Novartis

$87.04

2.58 (3.05%)

12:47
05/24/19
05/24
12:47
05/24/19
12:47
Hot Stocks
Novartis says wholesale acquisition cost of Zolgensma $2.125M »

AveXis, a Novartis…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

TIVO

TiVo

$6.87

0.04 (0.59%)

12:45
05/24/19
05/24
12:45
05/24/19
12:45
Options
TiVo call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Jun

12:45
05/24/19
05/24
12:45
05/24/19
12:45
General news
Breaking General news story  »

Week of 5/24 Baker-Hughes…

VWAGY

Volkswagen

$0.00

(0.00%)

12:42
05/24/19
05/24
12:42
05/24/19
12:42
Periodicals
Appeals court rules in favor of Volkswagen diesel car owners, Reuters reports »

A German appeals court…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNC

Centene

$56.30

0.85 (1.53%)

, WCG

WellCare

$267.57

-6.89 (-2.51%)

12:42
05/24/19
05/24
12:42
05/24/19
12:42
Periodicals
Third Point confirms Centene stake to CNBC, says WellCare deal in best interest »

CNBC tweeted: "Third…

CNC

Centene

$56.30

0.85 (1.53%)

WCG

WellCare

$267.57

-6.89 (-2.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 14

    Jun

  • 24

    Jun

  • 24

    Jun

  • 23

    Jul

SPY

SPDR S&P 500 ETF Trust

$282.86

0.67 (0.24%)

, IVV

iShares Core S&P 500

$284.83

0.69 (0.24%)

12:40
05/24/19
05/24
12:40
05/24/19
12:40
Technical Analysis
On The Fly: ETF fund flow highlights »

Flows for the past week…

SPY

SPDR S&P 500 ETF Trust

$282.86

0.67 (0.24%)

IVV

iShares Core S&P 500

$284.83

0.69 (0.24%)

XLK

Technology Select Sector SPDR

$73.62

0.33 (0.45%)

SMH

Market Vectors Semiconductor

$100.37

0.23 (0.23%)

SOXX

iShares PHLX Semiconductor ETF

$180.13

0.06 (0.03%)

LQD

iShares iBoxx $ Investment Grade Corporate Bond

$119.60

0.14 (0.12%)

EEM

iShares MSCI Emerging Markets ETF

$40.00

0.08 (0.20%)

XLU

Utilities SPDR

$59.99

0.07 (0.12%)

XLV

Health Care Select Sector SPDR

$89.56

0.17 (0.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSFT

Microsoft

$126.65

0.46 (0.36%)

, CCOEY

Capcom

$0.00

(0.00%)

12:37
05/24/19
05/24
12:37
05/24/19
12:37
Hot Stocks
Microsoft says Project xCloud can stream more than 3,500 games »

Kareem Choudhry,…

MSFT

Microsoft

$126.65

0.46 (0.36%)

CCOEY

Capcom

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jun

  • 03

    Jun

  • 08

    Jun

  • 10

    Jun

  • 10

    Jun

  • 11

    Jun

  • 23

    Jun

  • 06

    Aug

NVS

Novartis

$86.93

2.47 (2.92%)

12:33
05/24/19
05/24
12:33
05/24/19
12:33
Hot Stocks
Novartis announces FDA approval for Zolgensma »

AveXis, a Novartis…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

CNC

Centene

$55.37

-0.08 (-0.14%)

, WCG

WellCare

$273.18

-1.28 (-0.47%)

12:33
05/24/19
05/24
12:33
05/24/19
12:33
Periodicals
Third Point thinks Centene should consider sale before buying WellCare, WSJ says »

Daniel Loeb's Third…

CNC

Centene

$55.37

-0.08 (-0.14%)

WCG

WellCare

$273.18

-1.28 (-0.47%)

HUM

Humana

$262.97

3.1 (1.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 30

    May

  • 30

    May

  • 05

    Jun

  • 14

    Jun

  • 24

    Jun

  • 24

    Jun

  • 23

    Jul

  • 13

    Nov

NVS

Novartis

$86.95

2.49 (2.95%)

12:31
05/24/19
05/24
12:31
05/24/19
12:31
Hot Stocks
Breaking Hot Stocks news story on Novartis »

Novartis announces FDA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

KNX

Knight-Swift

$29.75

-0.65 (-2.14%)

12:30
05/24/19
05/24
12:30
05/24/19
12:30
Options
Volatility play opened in Knight Transportation »

Volatility play opened in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 13

    Nov

WCG

WellCare

$273.55

-0.91 (-0.33%)

, CNC

Centene

$55.41

-0.04 (-0.07%)

12:27
05/24/19
05/24
12:27
05/24/19
12:27
Periodicals
Breaking Periodicals news story on WellCare, Centene »

Activist Third Point has…

WCG

WellCare

$273.55

-0.91 (-0.33%)

CNC

Centene

$55.41

-0.04 (-0.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 14

    Jun

  • 24

    Jun

  • 24

    Jun

  • 23

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.